Associate Professor, Department of Surgery
The Ohio State University, USA
Dr. Zhiwei Hu is an associate professor of The Ohio State University College of Medicine. Prior to this position, he had held a faculty position as a research scientist (research associate professor) at Yale School of Medicineduring 2002-2012. Dr. Hu is one of first few scientists who proposed to target both the tumor cells and tumor neovasculature for development of more effective treatment for cancer. He co-inventedan Icon for dual neovascular- and cancer cell-targeted immunotherapyfor treatment of cancer, aged-related macular degeneration (AMD) and endometriosis in preclinical studies. Icon is now being tested in clinical trials for AMD patients. Recently his laboratory developed neovascular-targeted photodynamic therapy for cancer and AMD. Dr. Hu serves as a peer reviewer and an editorial board member for numerous scientific journalsin immunology, photodynamic therapy and cancer research, and as ad hoc grant reviewer for national and international research funding agencies. Since February 2012, he serves as Editor-in-Chief of The Journal of Analytical & Bioanalytical Techniques.
Tumor immunology, Oncology, Cancer immunotherapy, Diagnosis using monoclonal antibody,Phage display antibody,Recombinant factor VII/IgG1 Fc (Icon) immunoconjugates, Molecular biology, Adenoviral gene therapy for cancer, Experiences in targeted photodynamic therapy for cancer, Macular degeneration.